Search

loike

Opinion: The New Frontiers of Epigenetics
Opinion: The New Frontiers of Epigenetics
John D. Loike | Nov 12, 2018
Newly developed techniques could propel a field already advancing rapidly to complement modern medicine.
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
John D. Loike | Aug 16, 2018
Data don’t support many direct-to-consumer products, from telomere assessments to bespoke diets based on genetic sequences.
Opinion: Three-Parent Embryos—A Slippery Slope?
Opinion: Three-Parent Embryos—A Slippery Slope?
John D. Loike, Alan Kadish | Jun 14, 2018
The use of pronuclear transfer to treat infertility must first be backed by evidence it can work in cases where parents seek to avoid mitochondrial mutations.
Opinion: Should Human-Animal Chimeras Be Granted “Personhood”?
Opinion: Should Human-Animal Chimeras Be Granted “Personhood”?
John D. Loike | May 23, 2018
Determining which products of advanced biotechnology are deserving of legal protections is essential to our own social architecture.
Contributors
Contributors
Ben Andrew Henry | Jan 1, 2017
Meet some of the people featured in the January 2017 issue of The Scientist.
Infographic: The Cost of Drug Development
Infographic: The Cost of Drug Development
John D. Loike and Jennifer Miller | Feb 1, 2017
Expensive clinical trials and few drug approvals can drive up drug prices for consumers.
Week in Review: January 30–February 3
Week in Review: January 30–February 3
Joshua A. Krisch | Feb 3, 2017
March for science debate; an RNA vaccine for Zika; responses to Trump’s immigration order; native habitat restoration; views from local March for Science organizers; artificial cells and the Turing test
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Opinion: Ethical Considerations of “Three-Parent” Babies
Opinion: Ethical Considerations of “Three-Parent” Babies
John D. Loike and Nancy Reame | Dec 22, 2016
Mitochondrial replacement therapy raises important societal and ethical concerns, but should be embraced for its utility in preventing disease.
Life Science Controversies of 2016
Life Science Controversies of 2016
Bob Grant, Jef Akst, Tracy Vence | Dec 23, 2016
This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.

Refine your Search

Search Again